LATS1 and neoplasm: LATS1/2 activation can inhibit tumor growth (29, 30); however, Toshiro et al. recently reported that suppressing LATS1/2 exhibited antitumor immunity (14); therefore, the roles of LATS1/2 in the tumor microenvironment remain controversial.